Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma

[1] Karpel JP(2000)An easy-to-use dry-powder inhaler Adv Ther 17 282-286

[2] Yang TT(2001)Drug delivery performance of the mometasone furoate dry powder inhaler J Aerosol Med 14 487-494

[3] Li S(1999)Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler Respir Med 93 603-612

[4] Wyka B(2000)Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler Eur Respir J 16 808-816

[5] Kenyon D(2001)Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler Ann Allergy Asthma Immunol 86 36-43

[6] Bernstein DI(2004)Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma Pediatrics 113 1693-1699

[7] Berkowitz RB(2002)Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma Ann Allergy Asthma Immunol 88 306-312

[8] Chervinsky P(2001)Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma Allergy Asthma Proc 22 359-366

[9] Dvorin DJ(2006)Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial Pediatr Allergy Immunol 17 14-20

[10] Finn AF(1994)An open study to assess the long-term safety of fluticasone propionate in asthmatic children. International Study Group Br J Clin Pract 48 15-18

[1] Karpel JP(2000)An easy-to-use dry-powder inhaler Adv Ther 17 282-286

[2] Yang TT(2001)Drug delivery performance of the mometasone furoate dry powder inhaler J Aerosol Med 14 487-494

[3] Li S(1999)Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler Respir Med 93 603-612

[4] Wyka B(2000)Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler Eur Respir J 16 808-816

[5] Kenyon D(2001)Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler Ann Allergy Asthma Immunol 86 36-43

[6] Bernstein DI(2004)Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma Pediatrics 113 1693-1699

[7] Berkowitz RB(2002)Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma Ann Allergy Asthma Immunol 88 306-312

[8] Chervinsky P(2001)Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma Allergy Asthma Proc 22 359-366

[9] Dvorin DJ(2006)Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial Pediatr Allergy Immunol 17 14-20

[10] Finn AF(1994)An open study to assess the long-term safety of fluticasone propionate in asthmatic children. International Study Group Br J Clin Pract 48 15-18